ESSA Pharma, TransCode top healthcare gainers; Taysha Gene, AcelRx among losers

Oct. 26, 2022 10:02 AM ETEPIX, ACRX, NVRO, MRUS, FWBI, NXGN, TSHA, RNAZ, FEMY, TIVCBy: Ravikash, SA News Editor

stock market

hxdbzxy/iStock via Getty Images

  • Gainers: ESSA Pharma (EPIX+45%. TransCode Therapeutics (RNAZ) +35%. Femasys (FEMY) +16%. NextGen Healthcare (NXGN) +14%. First Wave BioPharma (FWBI+10%.
  • Losers: Taysha Gene Therapies (TSHA-19%. AcelRx Pharmaceuticals (ACRX) -17%. Merus (MRUS-11%. Nevro (NVRO) -7%. Tivic Health Systems (TIVC-6%.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.